my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Do you have a product idea or do you want to launch a started development onto the market within the shortest possible time? Then we are your perfect full-service OEM partner more
High-performance materials are enabling major advances in a wide range of applications from energy generation and digital information storage to disease screening and medical devices. Block polymers, which are two or more polymer chains with different properties linked together, show great promise f more
For the first time ever, a single flexible fiber no bigger than a human hair has successfully delivered a combination of optical, electrical, and chemical signals back and forth into the brain, putting into practice an idea first proposed two years ago. With some tweaking to further improve its bioc more
Methicillin-resistant Staphylococcus aureus (MRSA) infections are caused by a type of staph bacteria that has become resistant to the antibiotics used to treat ordinary staph infections. The rise of MRSA infections is limiting the treatment options for physicians and surgeons. Now, an international more
Drug and device development is a complex process which needs effective project management. With ever increasing pressures to complete the development of drugs and medical devices in ever shorter timescales, the use of project management can provide essential tools and techniques to achieve this. Ind
BioCAS 2017 serves as a premier international forum for presenting the interdisciplinary research and development activities at the crossroads of medicine, life sciences, physical sciences and engineering that will shape tomorrow’s medical devices and healthcare systems. This conference will enable
This seminar will provide a solid foundation in the approval and clearance processes for medical devices in the United States. Participants will gain an understanding of the underlying legal and regulatory requirements and the “general controls” applicable to all devices, including device classifica
Come and work with us as Life Cycle Management - Device Platform Manager (m/f) Packaging & Device Commercialization BTDM, Sandoz GmbH, Schaftenau Areas of Responsibility Responsible for the live cycle management of the device across device platform(s) within the Novartis wide Biologics Technical a more
Abstract This study quantified the changes of the frequency‐dependant viscoelastic properties of the BDyn (S14 Implants, Pessac, France) spinal posterior dynamic stabilization (PDS) device due to in vitro oxidation. Six polycarbonate urethane (PCU) rings and six silicone cushions were degraded u more
Publication date: Available online 1 June 2017 Source:Acta Biomaterialia Author(s): Jitendra Pant, Jing Gao, Marcus J. Goudie, Sean Hopkins, Jason Locklin, Hitesh Handa Although the use of biomedical devices in hospital-based care is inevitable, unfortunately, it is also one of the more
Medical devices have the potential to leach substances which, depending on the contact category of the device, can directly contact the human body. Hence, appropriate evaluation for genetic toxicity as part of the biocompatibility risk assessment is critical. The biocompatibility risk assessment o more
BMI View: While the Turkish pharmaceutical industry has achieved some concessions following additional price cuts and public discounts announced in November 2011, the impact of the November decree remains negative. That aside, BMI emphasises that the number-one concern for drugmakers in 2012 should more
BMI View: On account of its unpredictable and unfavourable operating environment and limited funding for and investment in healthcare and medicines, Zimbabwe’s pharmaceutical market will remain unattractive to foreign companies for the foreseeable future. Poor healthcare provision and coverage will more
BMI View: We retain our negative outlook for the pharmaceutical market in the Czech Republic, expecting a 1.8% contraction in its value in local currency terms in 2012, following the 1.0% year-onyear (y-o-y) decrease calculated for 2011. While the increase in the value-added tax (VAT) will negate th more
Watchlist
This is where you can add this topic to your personal favourites
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2017 CHEMIE.DE Information Service GmbH, All rights reserved
